A new study from the University of Oklahoma reveals how a little-understood protein, CD82, contributes to blood vessel leakage, a process that initiates inflammation but becomes dangerous when it occurs during severe inflammatory diseases such as sepsis, acute respiratory distress syndrome and COVID-19. The findings, published in Nature Cardiovascular Research, could open the door to new therapies aimed at protecting patients from multi-organ failure and death in severe and systemic inflammation.